Harnessing heterogeneity in type 2 diabetes mellitus

Personalizing Second-Line Type 2 Diabetes Treatment Selection: Combining Network Meta-analysis, Individualized Risk, and Patient Preferences for Unified Decision Support

(2019) Sung Eun Choi et al.   MEDICAL DECISION MAKING

Cardiovascular effects of pioglitazone or sulphonylureas according to pretreatment risk: moving towards personalized care

(2019) Olga Vaccaro et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A longitudinal big data approach for precision health

(2019) Sophia Miryam Schüssler-Fiorenza Rose et al.   NATURE MEDICINE

Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data

(2019) John M Dennis et al.   Lancet Diabetes & Endocrinology

Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study

(2019) Oana P Zaharia et al.   Lancet Diabetes & Endocrinology

Heterogeneity of diabetes: heralding the era of precision medicine

(2019) Stefano Del Prato   Lancet Diabetes & Endocrinology

Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine

(2019) Miriam S Udler et al.   ENDOCRINE REVIEWS

Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables

(2018) Emma Ahlqvist et al.   Lancet Diabetes & Endocrinology

Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis

(2018) Miriam S. Udler et al.   PLOS MEDICINE

Is type 2 diabetes a category error?

(2013) Edwin AM Gale   LANCET